Novel targeted strategies to overcome drug resistance in small cell lung cancer
Closed access
Author
Date
1996Type
- Doctoral Thesis
ETH Bibliography
yes
Altmetrics
Permanent link
https://doi.org/10.3929/ethz-a-001549708Publication status
publishedExternal links
Search print copy at ETH Library
Publisher
ETH ZürichSubject
KREBS UND TUMOREN DER ATMUNGSORGANE (PATHOLOGIE); ARZNEIMITTELRESISTENZ (PHARMAKOLOGIE); KREBSZELLEN (CYTOPATHOLOGIE); ZIELGERICHTETE ARZNEIMITTEL (PHARMAKOLOGIE); MONOKLONALE ANTIKÖRPER (IMMUNOLOGISCHE TECHNIKEN); ZELLGIFTE + CYTOTOXINE (TOXIKOLOGIE); CANCER AND TUMOURS OF RESPIRATORY ORGANS (PATHOLOGY); DRUG RESISTANCE (PHARMACOLOGY); CANCER CELLS (CYTOPATHOLOGY); TARGETED DRUGS (PHARMACOLOGY); MONOCLONAL ANTIBODIES (IMMUNOLOGICAL TECHNIQUES); CELL POISONS + CYTOTOXINS (TOXICOLOGY)Notes
Diss. Naturwiss. ETH Zürich, Nr. 11427, 1996. Ref.: Gerd Folkers ; Korref.: Uwe Zangemeister-Wittke.More
Show all metadata
ETH Bibliography
yes
Altmetrics